Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Renal Insufficiency 3Kidney Failure, Chronic 3Multiple Myeloma 2Carcinoma, Renal Cell 2Virus Diseases 1Renal Insufficiency, Chronic 1Kidney Diseases 1Hematologic Neoplasms 1Graft vs Host Disease 1Epstein-Barr Virus Infections 1

Interventions

Cyclophosphamide 64Tacrolimus 55Methotrexate 46Mycophenolic Acid 39Cyclosporine 37fludarabine phosphate 35Busulfan 35Antilymphocyte Serum 32fludarabine 29Sirolimus 26Melphalan 23Peripheral Blood Stem Cell Transplantation 22Radiotherapy 21Methylprednisolone 21Whole-Body Irradiation 19Filgrastim 17thymoglobulin 14Thiotepa 11Stem Cell Transplantation 10Rituximab 10ruxolitinib 9Granulocyte Colony-Stimulating Factor 9Prednisone 7Hematopoietic Stem Cell Transplantation 7Etoposide 7Cord Blood Stem Cell Transplantation 7Alemtuzumab 7Transplantation 6Pentostatin 6Cytarabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Kidney Transplantation × Clear all
NCT00062621 2013-02-05

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
5 enrolled
GenitourinaryPlasma cell

Graft vs Host Disease, Kidney Diseases, Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡